These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2189477)

  • 21. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
    Aleman BM; van Leeuwen FE
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hodgkin's disease. Treatment sequelae and quality of life.
    Henry-Amar M
    Baillieres Clin Haematol; 1996 Sep; 9(3):595-618. PubMed ID: 8922248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Incidence and significance of therapy-associated late toxicity in Hodgkin's disease].
    Streit M; Thiel E; Kreuser ED
    Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1093-9. PubMed ID: 7641593
    [No Abstract]   [Full Text] [Related]  

  • 24. Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease.
    Valagussa P; Santoro A; Bonadonna G
    Ann Oncol; 1992 Sep; 3 Suppl 4():111-5. PubMed ID: 1450071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cancer following treatment of Hodgkin disease].
    Lustman F; Nouwynck C
    Rev Med Brux; 1995; 16(3):138-40. PubMed ID: 7624666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second malignancy complicating Hodgkin's disease.
    Tawil E; Mercier JP
    J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence of long-term side effects--in particular induced leukemias following treatment for Hodgkin's disease.
    De Renzis C; Cellini N; Ausili Cefaro GP; Mantini G; Parisi S; Smaniotto D
    Rays; 1986; 11(2):109-13. PubMed ID: 3602444
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
    Lipton JH; Gospodarowicz M; Reingold S
    Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress and controversy in treatment of Hodgkin's disease].
    Robak T
    Acta Haematol Pol; 1995; 26(4):343-52. PubMed ID: 8571735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary treatment of advanced Hodgkin's disease].
    Illés A; Udvardy M; Molnár Z
    Orv Hetil; 2005 Jan; 146(5):195-202. PubMed ID: 15773586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute myeloid leukemia during Hodgkin's disease].
    Dziewulska-Bokiniec A; Jassem J
    Acta Haematol Pol; 1979; 10(2):137-40. PubMed ID: 289273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute non-lymphoblastic leukosis as a second neoplasm in Hodgkin's disease].
    Díaz Pérez MA; Zamora Auñón P; Escobar Alvarez Y; García de Parecdes ML
    Med Clin (Barc); 1985 Feb; 84(4):167. PubMed ID: 3982119
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
    Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
    Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The health state evaluation in persons after therapy of Hodgkin's disease in childhood: report of the Polish Pediatric Leukemia/Lymphoma Study Group].
    Balwierz W; Moryl-Bujakowska A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Sopyło B; Stańczak E; Sońta-Jakimczyk D; Janik-Moszant A; Chybicka A; Chaber R; Kowalczyk JR; Odój T; Balcerska A; Stachowicz-Stencel T; Wysocki M; Kołtan A; Kołtan S; Krawczuk-Rybak M; Muszyńska-Rosłan K; Zuj G;
    Przegl Lek; 2006; 63(1):25-8. PubMed ID: 16892895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Late complications in patients cured of neoplasms in childhood].
    Armata J; Balwierz W
    Przegl Lek; 1992; 49(3):69-72. PubMed ID: 1438897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late therapy-induced cardiac and pulmonary complications in cured patients with Hodgkin's disease treated with conventional combination chemo-radiotherapy.
    Polliack A
    Leuk Lymphoma; 1995; 15 Suppl 1():7-10. PubMed ID: 7767265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hodgkin's disease: complications of therapy and excess mortality.
    Hoppe RT
    Ann Oncol; 1997; 8 Suppl 1():115-8. PubMed ID: 9187444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary veno-occlusive disease and Hodgkin's lymphoma.
    Swift GL; Gibbs A; Campbell IA; Wagenvoort CA; Tuthill D
    Eur Respir J; 1993 Apr; 6(4):596-8. PubMed ID: 8491311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications in the treatment of Hodgkin's disease.
    Alberts AS; Goedhals L
    S Afr Med J; 1987 Sep; 72(6):401-4. PubMed ID: 3660127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.